Recommended pre-submission checks
Powered by 

MedComm – Future Medicine Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Wiley |
| Language | English |
| Article Processing Charges | USD 2600 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Sichuan International Medical Exchange & Promotion Association (SCIMEA) |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in MedComm – Future Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in MedComm – Future Medicine
Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies
- 1 Mar 2026
- MedComm – Future Medicine
The DYRK Family: A Key Regulator of Metabolic Homeostasis and Its Therapeutic Potential in Kidney Diseases
- 1 Mar 2026
- MedComm – Future Medicine
Title not available
- 1 Mar 2026
- MedComm – Future Medicine
IgE‐Sensitized Mast Cells: A Programmable Platform for Antigen‐Triggered Oncolytic Virotherapy
- 1 Mar 2026
- MedComm – Future Medicine
MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential
- 1 Mar 2026
- MedComm – Future Medicine
Issue Information
- 29 Jan 2026
- MedComm – Future Medicine
Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies
- 1 Mar 2026
- MedComm – Future Medicine
The DYRK Family: A Key Regulator of Metabolic Homeostasis and Its Therapeutic Potential in Kidney Diseases
- 1 Mar 2026
- MedComm – Future Medicine
Title not available
- 1 Mar 2026
- MedComm – Future Medicine
IgE‐Sensitized Mast Cells: A Programmable Platform for Antigen‐Triggered Oncolytic Virotherapy
- 1 Mar 2026
- MedComm – Future Medicine
MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential
- 1 Mar 2026
- MedComm – Future Medicine
Issue Information
- 29 Jan 2026
- MedComm – Future Medicine